Follow us on Twitter
twitter icon@FreshPatents


Factor patents

      

This page is updated frequently with new Factor-related patent applications.




 Time spaced infrared image enhancement patent thumbnailTime spaced infrared image enhancement
Techniques using small form factor infrared imaging modules are disclosed. An imaging system may include visible spectrum imaging modules, infrared imaging modules, and other modules to interface with a user and/or a monitoring system.
Flir Systems, Inc.


 Enlarged substrate for magnetic recording medium patent thumbnailEnlarged substrate for magnetic recording medium
A data storage device having a housing member for a selected one of a 3½ inch form factor hard disc drive (hdd) or a 2½ inch form factor hdd. A spindle motor coupled to the housing member supports a rotatable data recording disc with a plurality of data tracks and an outermost perimeter.
Seagate Technology Llc


 Systems, methods and articles to provide olfactory sensations in a social network environment patent thumbnailSystems, methods and articles to provide olfactory sensations in a social network environment
Systems and methods for dispensing scents in a social network environment. Users of a social network service can combine visual, audio, and olfactory effects into digital posts or messages that can be experienced by other users of the social network service.
Vapor Communications, Inc.


 Tnt based diagnosis of paroxysmal atrial fibrillation patent thumbnailTnt based diagnosis of paroxysmal atrial fibrillation
The present invention relates to a method for diagnosing a recent paroxysmal atrial fibrillation. The method is based on the determination of the at least one marker selected from the group consisting of a cardiac troponin, nt-probnp (n-terminal prohormone of brain natriuretic peptide), hscrp, il-6 (interleukin-6) and igfbp7 (insulin like growth factor binding protein 7) in a sample from the subject, and on the comparison of the, thus, determined amount(s) with a reference amount (reference amounts).
Roche Diagnostics Operations, Inc.


 Heat pipes with electrical pumping of condensate patent thumbnailHeat pipes with electrical pumping of condensate
A heat pipe with electrical pumping. The heat pipe includes a condenser to condense vapor into liquid droplets and an evaporator for the liquid-vapor conversion.
Board Of Regents, The University Of Texas System


 Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy patent thumbnailImpact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy
Pharmacogenetic analysis revealed an effect of risk alleles in arms2 and cfh genes on the response of subjects to anti-c5 antibodies in the treatment of the progression of geographic atrophy.. .
Novartis Ag


 Perfume compositions patent thumbnailPerfume compositions
Perfume compositions having controlled spatio-temporal olfactory profiles are described. The disclosure also relates also to a method of measuring said spatial-temporal olfactory profiles of said compositions..
Givaudan Sa


 Egfr targeted therapy of neurological disorders and pain patent thumbnailEgfr targeted therapy of neurological disorders and pain
The present invention relates to compositions and methods for treatment of neurological disorders. In particular, the present invention relates to the epidermal growth factor receptor (egfr) as a clinical target for treatment of neurological disorders, preferably in conjunction with neuropathic pain.
Sykehuset Sørlandet Hf


 Vegf antagonist formulations patent thumbnailVegf antagonist formulations
Formulations of a vascular endothelial growth factor (vegf)-specific fusion protein antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the fusion protein has the sequence of seq id no:4..
Regeneron Pharmaceuticals, Inc.


 Compositions and methods for growth factor modulation patent thumbnailCompositions and methods for growth factor modulation
Provided herein are proteins, antibodies, assays and methods useful for modulating growth factor levels and/or activities. In some embodiments, such growth factors are members of the tgf-β superfamily of proteins..
Scholar Rock, Inc.


Factor viii chimeric proteins and uses thereof

The present invention provides a chimeric protein comprising a first polypeptide which comprises a fviii protein and a first ig constant region or a portion thereof and a second polypeptide which comprises a vwf protein comprising the d′ domain and d3 domain of vwf, a xten sequence having less than 288 amino acids in length, and a second ig constant region or a portion thereof, wherein the first polypeptide and the second polypeptide are associated with each other. The invention also includes nucleotides, vectors, host cells, methods of using the chimeric proteins..
Biogen Ma Inc.

Substituted tetrahydroisoquinoline compounds as factor xia inhibitors

Or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor xia and/or plasma kallikrein which may be used as medicaments..

Multivalent ligands targeting vegfr

Compounds that target vascular endothelial growth factor receptors for therapy and imaging are disclosed. Methods for making the compounds and detecting or imaging cells expressing vegfr using the compounds are also provided.
The Methodist Hospital System

Platelet-derived growth factor compositions and methods of use thereof

A method for promoting growth of bone, periodontium, ligament, or cartilage in a mammal by applying to the bone, periodontium, ligament, or cartilage a composition comprising platelet-derived growth factor at a concentration in the range of about 0.1 mg/ml to about 1.0 mg/ml in a pharmaceutically acceptable liquid carrier and a pharmaceutically-acceptable solid carrier.. .
Biomimetic Therapeutics, Llc

Platelet-derived growth factor compositions and methods of use thereof

A method for promoting growth of bone, periodontium, ligament, or cartilage in a mammal by applying to the bone, periodontium, ligament, or cartilage a composition comprising platelet-derived growth factor at a concentration in the range of about 0.1 mg/ml to about 1.0 mg/ml in a pharmaceutically acceptable liquid carrier and a pharmaceutically-acceptable solid carrier.. .
Biomimetic Therapeutics, Llc

Injectable chitosan sponges for enhancing bone regeneration

It is provided a chitosan sponge for bone regeneration in a subject, comprising chitosan; a purine compound such as guanosine 5′-diphosphate (gdp); and at least one of a growth factor and a pyrophosphatase. Preferably the growth factor is bmp-7.
The Royal Institution For The Advancement Of Learning / Mcgill University

Anti-egfr antibodies and antibody drug conjugates

The invention relates to anti-epidermal growth factor (egfr) antibodies and antibody drug conjugates (adcs), including compositions and methods of using said antibodies and adcs.. .
Abbvie Inc.

Treatment of neonatal brain injury with hb-egf

Methods for treating brain injury caused by or associated with hypoxia or a hypoxic state, especially neonatal brain injury, using heparin-binding egf-like growth factor.. .
Children's National Medical Center

Dynamic biological and chemical sensor interfaces

A dynamic sensor interface is provided. Such a dynamic sensor interface may include a reaction layer that includes a biological-based or chemical-based ink that reacts in response to a molecule of interest, a porous membrane that allows for the molecule of interest to pass through to a side that is in contact with the reaction layer, and an adhesive substrate.
Bioink Corporation

Furniture filling

A pillow and its method of creation are provided. The pillow, or other filled item, begins as a piece of fabric that is filled with a blend of discrete amounts of latex, and a volume of fiberfill.
Pegasus Home Fashions, Inc.

Systems, methods and articles to provide olfactory sensations

Systems and methods for dispensing scents. A beacon transmits short-range wireless signals to detect mobile devices located proximate to the beacon.
Vapor Communications, Inc.

All-acoustic duplexers using directional couplers

An all-acoustic filter includes acoustic directional couplers and acoustic filters. In one embodiment, the all-acoustic filter includes two acoustic directional couplers, pair of matched acoustic filters corresponding to either transmit or receive frequency bands, and another acoustic filter corresponding to the other of transmit or receive frequency bands.
Abtum Inc.

Wideband wide beamwidth mimo antenna system

A two antenna assembly for use in mimo systems is described where wide beamwidth performance is achieved over wide frequency ranges while maintaining high isolation and low envelope correlation between the antenna elements in a low profile, small form factor. This mimo antenna system is optimal for use in das systems for in-building applications where a mimo antenna system is required and a low profile is desirable for ceiling and wall mount applications.
Ethertronics, Inc.

Method for estimating use state of power of electric devices

A method includes estimating a model parameter in a case where operating states of plural electric devices are modeled by a probability model by using a total value of power consumption of the plural electric devices connected with a panel board. In the estimating, the model parameter in which likelihood calculated by a likelihood function becomes a maximum is estimated based on characteristics of power data that may be predetermined as prior knowledge from an operation tendency of each of the plural electric devices, the probability model is a factorial hidden markov model (fhmm), and the likelihood is a value that indicates certainty of a pattern of a total value of the power consumption, which is modeled by the fhmm, of the plural electric devices with respect to a total value of the power consumption that is actually measured..
Panasonic Intellectual Property Corporation Of America

Active odor cancellation

The present disclosure relates to methods, devices and systems for calculating or selecting a first set of chemical compounds for an odor additive. For example, a method identifies a second set of chemical compounds present in a sample and intensities of individual chemical compounds in the second set of chemical compounds, and calculates the first set of chemical compounds for the odor additive such that an olfactory perception of a mixture of the sample and the odor additive is an olfactory white..
International Business Machines Corporation

Nuclear localization of src-family tyrosine kinases is required for growth factor-induced euchromatinization

A method for quantitatively evaluating chromatin structural changes using pixel imaging of the nucleus is provided. Pixel imaging of the nucleus can include capturing one or more images of a nucleus of one or more nucleic acid stain treated cells.
National University Corporation Chiba University

Novel mutation in the epidermal growth factor receptor kinase domain

A new in-frame deletion was found in exon 19 of the egfr gene, the exon that is often mutated in tumors. The invention comprises methods of detecting the mutation, methods of prognosis and methods of predicting response to treatment based on the presence of absence of the mutation..
Roche Molecular Systems, Inc.

Transcription factor sequences for conferring advantageous properties to plants

The invention relates to plant transcription factor polypeptides, polynucleotides that encode them, homologs from a variety of plant species, and methods of using the polynucleotides and polypeptides to produce transgenic plants having advantageous properties compared to a reference or control plant, including increased plant size, seed size, increased leaf size, lignification, water deprivation tolerance, cold tolerance, or altered flowering time. Sequence information related to these polynucleotides and polypeptides can also be used in bioinformatic search methods and is also disclosed..
Mendel Biotechnology, Inc.

Plants having one or more enhanced yield-related traits and a making the same

Provided is a method for enhancing one or more yield-related traits in a plant by modulating expression in the plant of a nucleic acid encoding an anac055 (arabidopsis no apical meristem, arabidopsis transcription factor, cup-shaped cotyledon) polypeptide. Also provided are plants having modulated expression of a nucleic acid encoding an anac055 polypeptide, which plants have one or more enhanced yield-related traits compared with control plants.
Basf Plant Science Company Gmbh

Microrna treatment of fibrosis

Provided herein are micrornas that target transforming growth factor beta (tgf-β) receptors and attenuate pathways of fibrosis. In particular, microrna-1343 reduces expression of tgfbr1 and tgfbr2, decreases tgf-β signaling, represses pathways of fibrosis, and treats fibrotic diseases..

Method for in situ inhibition of regulatory t cells

The present invention pertains to engineered t-cells, method for their preparation and their use as medicament, particularly for immunotherapy. The engineered t-cells of the invention are designed to express both a chimeric antigen receptor (car) directed against at least one antigen expressed at the surface of a malignant or infected cell, and a secreted inhibitor of regulatory t-cells (treg).
Cellectis

Enhancement of recombinant protein expression with copper

The present invention provides a novel use of copper (cupric ion) for improved cell expression of recombinant proteins, particularly coagulation proteins such as recombinant factor viii, b domain deleted recombinant factor viii, recombinant factor ix and rfvii or rfviia. The use of such cell culture supplement results in higher productivity and robustness of the manufacturing process.
Advantech Bioscience Farmacêutical Ltda

Inkjet-printable foil balloon and it's fabrication

An inkjet printer-ready foil balloon comprises an ink-absorbing material and a special assembling form for the balloon, which allows an end user to personalize and print to the balloon on a conventional inkjet printer. The ink-absorbing material enables the balloon surface to become receptive to inkjet inks while a technique of manufacturing ensures that the balloon fits the form factor of a conventional inkjet printer..
Brother International Corporation

Antibodies to tgf-beta

The present invention relates to antibody molecules, in particular antibody molecules that bind. Transforming growth factor beta (tgfβ), and uses thereof.
Optein, Inc.

Monoclonal antibody against human prpc and use thereof

A monoclonal antibody against human prpc protein capable of reducing the expression level of transcription factor twist1 in a targeting mode and inducing macrophage and nk cells to target to rectal cancer tumor cells. The combined drug therapy with the antibody and cetuximab also exhibits inhibitory effect on tumor better than administration of the antibody or cetuximab alone..
Institute Of Zoology, Chinese Academy Of Sciences

Factor viii variants having a decreased cellular uptake

The present invention relates to modified coagulation factors. In particular, the present invention relates to modied factor viii molecules having decreased cellular uptake..
Sanquin Blood Supply Foundation

Inhibitors of the fibroblast growth factor receptor

Described herein are inhibitors of fgfr, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of tyrosine kinases.. .
Blueprint Medicines Corporation

Solubility for target compounds

The present disclosure relates to compounds having an improved solubility thereby increasing their bioavailability, lower dosages, etc. The target compounds, may include but are not limited to, macrophage migration inhibitory factor (mif) inhibitors, epidermal growth factor receptor (egrf) inhibitors, kinase inhibitors and prodrugs of alpha4 beta1 and alpha4 beta7 integrin antagonists.
Aunova Medchem Llc

Indolinone compounds and uses thereof

Indolinone derivative compounds that act as ews-fli1 transcription factor inhibitors are provided. Also provided are pharmaceutical compositions of the indolinone derivatives, methods of synthesizing the same, methods of treating using same, and assays for identifying the inhibitors of ews-fli1 oncoprotein..
Oncternal Therapeutics, Inc.





Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Factor for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Factor with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.1349

file did exist - 2778

2 - 1 - 55